8
Views
13
CrossRef citations to date
0
Altmetric
Original

Intra-Arterial Infusion of Prostaglandin E1 in Normal Subjects and Patients with Peripheral Arterial Disease

, , , , &
Pages 633-640 | Received 20 Feb 1976, Accepted 02 Sep 1976, Published online: 14 Feb 2011
 

Abstract

Nielsen, P. E., Levin Nielsen, S., Holstein, P., Lönsmann Poulsen, H., Hart Hansen, E. & Lassen, N. A. Intra-Arterial Infusion of Prostaglandin E1 in Normal Subjects and Patients with Peripheral Arterial Disease. Scand. J. clin. Lab. Invest. 36, 633–640, 1976.

Acute vasodilatation was produced by infusion of prostaglandin E1 (PGE1) in the femoral artery in 6 patients with occlusive arterial disease of the legs and in 3 normal subjects. The effect on blood flow and on blood pressure was measured at different segments of the leg with the strain gauge technique, isotope clearance technique, and photoelectric technique. Skin temperature was measured at different levels by using thermocouples. The blood pressure on the legs decreased at all segments during vasodilatation as well in patients as in controls. The blood flow increased in all segments in normal controls. In patients the blood flow increased proximally in the legs. Distally, however, no increase could be demonstrated. As a good effect of PGE1 on ischaemic rest pains has been reported, mechanisms other than vasodilatation should probably be considered.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.